Research on treating disease with medication. Covers psychedelics, combination cancer therapy, opioid treatment in pregnancy, and personalized guidelines.
Patients with interstitial lung disease often experience significant treatment burdens, including drug-disease interactions. The study highlights the importance of careful evaluation before treatment initiation to minimize complications.
A clinical trial found sacituzumab govitecan produced a significant treatment response in patients with difficult-to-treat metastatic triple-negative breast cancer, outperforming standard chemotherapy. The drug showed manageable side effects and improved treatment duration.
The American Academy of Sleep Medicine published a clinical practice guideline for the use of positive airway pressure (PAP) therapy to treat obstructive sleep apnea (OSA) in adults. The guideline provides nine recommendations, including the use of PAP therapy as a first-line treatment for OSA in adults with excessive sleepiness.
Researchers conducted an extensive comparison of all drugs used in neuroendocrine tumor treatment, guiding physicians through available options. Combination therapies showed high efficacy, but were often underrepresented in international guidelines.
Recent advances in understanding Parkinson's disease have identified promising developments to slow or stop its progression. Researchers explore new therapeutic targets, targeting non-motor features of the disease, and repurposing drugs for their potential disease-modifying properties.
A team of researchers has identified a potential new therapeutic target for Alzheimer's disease by suppressing the activity of a signaling molecule called eEF2K. This approach may improve protein synthesis capacity and alleviate cognitive and synaptic impairments associated with the disease.
A new drug candidate, givosiran, has shown promising results in treating acute porphyria by preventing attacks and reducing hemin need by up to 83%, according to a recent clinical trial. The study's lead author notes that the treatment can effectively prevent acute attacks in seriously afflicted patients with limited options.
A study published in Restorative Neurology and Neuroscience found that eight weeks of intensive yoga practice significantly decreases the severity of physical and psychological symptoms in patients with active rheumatoid arthritis. The results show marked improvements in inflammatory biomarkers, functional status, and disease activity.
New guidelines developed by an international expert panel emphasize the importance of treating neuropsychiatric disorders in HD patients. The guidelines provide general, behavioral, and pharmacologic recommendations for managing symptoms such as agitation, anxiety, apathy, psychosis, and sleep disorders, and highlight the need for regu...
Researchers found that mechanical clot removal can limit disability and improve functional outcomes in stroke patients up to 24 hours after symptom onset. This study suggests that endovascular therapy beyond the normal treatment window can lead to better quality of life for stroke survivors.
A new assay accurately measures TNF concentrations during adalimumab treatment, revealing that circulating TNF levels increase 50-fold before stabilizing. Lower TNF concentrations after the fourth week are associated with more antibodies against the drug and a lower chance of remission.
Researchers found incomplete and outdated compendia lists of medications and their uses, leading to denied coverage decisions without appeals. Dermatologists face challenges due to the lack of transparency in approval processes.
A new Northwestern University study identifies four factors that can accurately predict the severity and longevity of postpartum depression in new mothers. The study found that early intervention can improve treatment outcomes, and clinicians can tailor care to individual women's needs.
IDIBELL researchers discovered a novel disease affecting brain white matter in children, caused by DEGS1 gene defect. Fingolimod treatment shows promise in correcting ceramide imbalances and promoting oligodendrocyte survival.
Researchers found a significant association between schizophrenia and increased antibody levels against the Epstein-Barr virus. The study suggests that individuals with schizophrenia may be more susceptible to EBV infection due to an abnormal immune response.
Researchers used noncontact imaging to differentiate malignant cells and monitor treatment effectiveness, revealing mechanical properties of tumors that influence disease progression. This technique may lead to personalized therapies and more effective treatments.
Researchers found that aromatase inhibitors suppress estrogen synthesis, but paradoxically increase estrogen levels in the brain, leading to memory and thermal regulation deficits. The study calls for new therapies to prevent breast cancer recurrence while minimizing side effects.
Researchers successfully treated a patient with disfiguring sarcoidosis using a drug approved for rheumatoid arthritis. The treatment showed promising results in reducing skin lesions and halting the activation of the Jak-STAT pathway.
A team of researchers at Washington University in St. Louis has made a significant step towards precision medicine for patients with Long QT Syndrome Type 3, a life-threatening form of irregular heartbeat. By analyzing genetic variation and the nanoscale interaction of a commonly used drug treatment, they determined which patients woul...
A systematic review of clinical studies on prurigo nodularis treatment found neurokinin-1 receptor antagonists to be the most promising emerging therapies. The study highlights the need for higher-powered studies and randomized controlled trials to better evaluate treatment options.
Researchers at Kanazawa University have discovered that a baculovirus can completely eliminate liver-stage malaria parasites in mice. The study suggests a new approach to developing non-haemolytic single-dose alternative drugs for P. vivax treatment, potentially reducing the risk of infection and side effects.
A new transgenic mouse model with fluorescent proteins can quickly reflect therapeutic effects in living mice, allowing for rapid identification of promising treatments. The model was used to test a novel antisense oligonucleotide drug that demonstrated therapeutic activity and corrected aberrant RNA splicing.
The phase-2 JULIET trial found that CAR-T cell therapy achieved a 52% favorable response rate in patients with relapsed or refractory diffuse large B-cell lymphoma, with 40% experiencing complete responses. Sixty-five percent of patients remained relapse-free after one year.
Researchers found that checkpoint blockade therapy can sensitize patients to better respond to future use of drugs, even when initial attempts failed. This breakthrough has significant implications for treating relapsing non-Hodgkin lymphoma and Hodgkin lymphoma patients.
A new study from King's College London found that breathlessness-focused services can significantly reduce patient distress and symptoms of depression. These holistic services, which combine palliative care and self-management strategies, empower patients to take control of their breathlessness and improve their quality of life.
A new study highlights the need for a shift in mental health provision based on public views and individual perspectives. Mental health professionals should adapt their practice to acknowledge patients' beliefs and preferences, rather than relying on assumed assumptions.
Researchers discovered that malaria parasites adjust their reproduction strategy based on host conditions, opting to invest more in reproduction when conditions are favorable and prioritizing survival during adverse times. This finding could inform the development of new treatments by prompting parasites to spread more easily.
Researchers have created an oral formulation of semaglutide, a successful type 2 diabetes therapy, that can be more readily absorbed in the stomach. This development has the potential to improve treatment flexibility and patient adherence to T2D treatment programs, offering patients a less invasive route of administration.
Researchers at MD Anderson Cancer Center report high response rates of 90% among frontline-treated patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The study, led by Naveen Pemmaraju, presents a novel targeted therapy targeting CD-123, a cell surface receptor expressed in BPDCN and other hematologic malignancies.
Indiana University researchers observed nanoparticles rotate differently when binding to receptors, indicating varying levels of cellular binding strength. This discovery could lead to more effective drug treatments and improved immunotherapy.
A new study found that personalized medicine technique reduced treatment times by up to 6 weeks, with 21 patients remaining virus-free and no significant loss of efficacy. The results have the potential to save $10 billion annually in healthcare costs.
Researchers have identified a drug that inhibits the signalling pathway of enzyme MEKK3, a process contributing to cerebral cavernous malformations (CCM), a leading cause of stroke in young people. A suitable candidate, Ponatinib, is currently used to treat cancer patients and may offer a non-invasive treatment option.
Researchers at The Feinstein Institute for Medical Research used genetic tests to predict patient response to antipsychotic medication in schizophrenia patients. They found higher polygenic risk scores were associated with reduced effectiveness of conventional treatment.
A new study reveals that states expanding Medicaid from 2011 to 2017 experienced a significant 27% increase in prescriptions for hormonal therapy medications compared to non-expansion states. This rise was attributed to increased access for previously uninsured women who required long-term treatment with these life-saving drugs.
Researchers at Duke-NUS Medical School and Singapore General Hospital develop a fully human system to cultivate skin cells for grafting, eliminating the need for animal-derived products. This breakthrough method uses specific laminin proteins to support the growth of human keratinocytes in the laboratory.
A small observational study suggests that rose geranium oil spray can help alleviate nasal vestibulitis, a common and painful condition caused by cancer drug treatment. The study found that 55% of participants experienced moderate benefit from using the oil, with some reporting complete symptom resolution.
A small study found that rose geranium oil spray in sesame oil base helped reduce the severity of nasal vestibulitis symptoms, which are common side effects of chemotherapy. The oil was used by 20 women on chemotherapy, with most reporting moderate to substantial benefits.
A phase II clinical trial found that sparsentan significantly reduces proteinuria by 45% in patients with focal segmental glomerulosclerosis (FSGS), a rare kidney disorder. The study also suggests potential implications for other kidney diseases characterized by proteinuria.
The HOBOE-2 trial found that zoledronic acid plus letrozole improved disease-free survival in premenopausal women with HR+ early breast cancer, with a 5-year DFS probability of 0.93 compared to 0.85 for tamoxifen. The combination treatment reduced breast cancer recurrence and mortality by nearly half.
A new study found that factors such as extraversion, openness, independence, and social support positively impact mental wellbeing in young adults with kidney failure. Higher medication adherence was linked to living with parents, conscientiousness, and physician access satisfaction.
A survey found that Americans wish doctors discuss their mental, spiritual, and lifestyle factors with them. Most patients want to talk about why they're healthy, non-drug treatments, and factors influencing overall well-being.
Scientists at Northwestern University have created a bioelectronic medicine that uses electrical stimulation to accelerate nerve regeneration and improve muscle strength in rats. The device, made of biodegradable materials, is powered wirelessly and operates for up to two weeks before naturally absorbing into the body.
A large multi-ethnic study found that high circulating levels of an inflammatory marker are linked to long-term decline in kidney function. The study suggests a novel marker, soluble TNFR-1, is strongly related to kidney function decline over time.
Researchers discuss historical and current evidence-based approaches to stimulating female sexual desire, highlighting the role of dopamine and music in enhancing pleasure. The study aims to improve healthcare providers' understanding of women's sexual health, particularly those affected by hypoactive sexual desire disorder.
Researchers at Mayo Clinic developed a new genetics-based prognostic tool for myelodysplastic syndrome, which integrates genetic and clinical information to provide more accurate predictions. The tool identifies favorable gene mutations, such as SF3B1, and unfavorable mutations, like ASXL1 and RUNX1, to guide treatment decisions.
A study published in eBioMedicine found that the absence of four particular genes in the Leishmania infantum parasite makes it less susceptible to miltefosine, an oral drug used to treat visceral leishmaniasis. This discovery could lead to a new prognostic test to predict treatment outcomes and tailor medicines accordingly.
The ASBMR Fracture Prevention Initiative Coalition releases new clinical recommendations to tackle the public health crisis of osteoporosis and its debilitating hip and spine fractures. The guidelines aim to increase diagnosis and treatment of high-risk individuals, particularly those over 65 with a history of hip or vertebral fractures.
A large-scale international study published in PLOS Medicine found that a new medication called Nilvadipine showed promise in slowing the progression of mild and moderate Alzheimer's disease. However, the overall group of patients did not benefit from the treatment. Further research is needed to explore its potential.
A new study reveals that black women are more likely to skip hormone therapy treatments for breast cancer, with barriers including cost, side effects, and difficulty adhering to treatment plans. The study highlights the need for culturally competent behavioral interventions to improve outcomes for all women with breast cancer.
Crowdfunding sites have seen a surge in UK cancer-related appeals, with £8m raised since 2012. Critics argue that these platforms are not adequately vetting appeals, potentially leading to patients being exploited by unproven treatments.
A large study found that commencing treatment for sleep apnea after a stroke significantly improves speech impairment, neurological symptoms, and physical functioning. The diagnosis and treatment of sleep apnea with CPAP therapy provides benefits greater than the FDA-approved drug treatment for stroke.
The American College of Medical Genetics and Genomics emphasizes the need for affordable treatment options for rare and ultra-rare diseases. Key recommendations include preventing abuses of the Orphan Drug Act and aligning drug packaging with dosing recommendations to reduce waste. The organization urges policymakers to develop simple,...
Researchers have discovered that neurons themselves trigger the immune system response in Rasmussen's encephalitis, leading to synaptic damage. By blocking this signalling pathway, they may be able to develop new treatments for the disease.
The BASKET-SMALL 2 trial found that a removable balloon is as good as a permanent stent for opening small blocked arteries, with no significant differences in major adverse cardiac events. The study showed improved outcomes without the need for prolonged treatment with anticlotting medicines.
The 2018 Fourth Universal Definition of Myocardial Infarction provides clarity on diagnosing a heart attack, distinguishing between myocardial infarction and myocardial injury. Elevated troponin levels are not sufficient for diagnosis, and oxygen shortage detection via electrocardiogram is crucial.
A randomized clinical trial found that a pill containing low doses of three antihypertensive drugs resulted in a greater percentage of patients achieving their target blood pressure goal. The study included 700 patients in Sri Lanka who were not receiving treatment or taking one medication.
Neurologist Camilo R. Gomez argues that the effect of time on ischemic stroke outcomes varies greatly among patients, with collateral circulation playing a critical role in determining treatment efficacy. He proposes a new approach to stroke care, taking into account individual patient variability and blood circulation patterns.
A KAIST research team has developed a flexible drug delivery device with controlled release, blurring the path toward theragnosis. The device boasts fewer side effects and uniform therapeutic results compared to oral ingestion, making it suitable for smart contact lenses and brain disease treatments.
A review suggests that cannabidiol, a compound in cannabis, may have modest efficacy in treating severe epilepsy, particularly in children. However, more rigorous clinical trials are necessary to fully understand its potential and minimize side effects.
A new study from McGill University Health Centre reveals that a four-month rifampin treatment is as effective as nine months of isoniazid in preventing tuberculosis, with significantly fewer side effects. The treatment was also more acceptable to patients, particularly those with liver toxicity.